Treatment of cervical cancer with the new dual topoisomerase inhibitor P8-D6

¹ Department of Gynaecology and Obstetrics, University and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Deutschland

² Pharmaceutical Institute, Department of Pharmaceutical and Medicinal Chemistry, Christian-Albrecht University of Kiel, Kiel, Deutschland

¹ Department of Gynaecology and Obstetrics, University and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Deutschland

¹ Department of Gynaecology and Obstetrics, University and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Deutschland

¹ Department of Gynaecology and Obstetrics, University and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Deutschland

³ Clinic of Radiotherapy, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Deutschland

³ Clinic of Radiotherapy, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Deutschland

⁴ Institute of Experimental Haematology, Hannover Medical School, Hannover, Deutschland

⁴ Institute of Experimental Haematology, Hannover Medical School, Hannover, Deutschland

¹ Department of Gynaecology and Obstetrics, University and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Deutschland

² Pharmaceutical Institute, Department of Pharmaceutical and Medicinal Chemistry, Christian-Albrecht University of Kiel, Kiel, Deutschland

¹ Department of Gynaecology and Obstetrics, University and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Deutschland

⁵ Department of Gynaecology, Jena University Hospital, Jena, Deutschland

¹ Department of Gynaecology and Obstetrics, University and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Deutschland

² Pharmaceutical Institute, Department of Pharmaceutical and Medicinal Chemistry, Christian-Albrecht University of Kiel, Kiel, Deutschland